

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 9.01864434 |
| 2 | polyketide metabolic process (GO:0030638) | 9.01864434 |
| 3 | doxorubicin metabolic process (GO:0044598) | 9.01864434 |
| 4 | nuclear pore complex assembly (GO:0051292) | 6.67706617 |
| 5 | maintenance of protein location in nucleus (GO:0051457) | 6.25782979 |
| 6 | regulation of response to osmotic stress (GO:0047484) | 6.17676092 |
| 7 | somite rostral/caudal axis specification (GO:0032525) | 6.06476192 |
| 8 | negative regulation of epidermis development (GO:0045683) | 5.95276914 |
| 9 | nuclear pore organization (GO:0006999) | 5.84853672 |
| 10 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.71235870 |
| 11 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.67547940 |
| 12 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.24812370 |
| 13 | muscle organ morphogenesis (GO:0048644) | 5.21053825 |
| 14 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.10355000 |
| 15 | regulation of posttranscriptional gene silencing (GO:0060147) | 5.08386025 |
| 16 | regulation of gene silencing by miRNA (GO:0060964) | 5.08386025 |
| 17 | regulation of gene silencing by RNA (GO:0060966) | 5.08386025 |
| 18 | pore complex assembly (GO:0046931) | 5.07179829 |
| 19 | DNA unwinding involved in DNA replication (GO:0006268) | 5.00106844 |
| 20 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.95268901 |
| 21 | ribosome assembly (GO:0042255) | 4.87813701 |
| 22 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.78413537 |
| 23 | response to dietary excess (GO:0002021) | 4.61464801 |
| 24 | mitotic sister chromatid cohesion (GO:0007064) | 4.49952636 |
| 25 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.48611938 |
| 26 | notochord development (GO:0030903) | 4.44055925 |
| 27 | hormone catabolic process (GO:0042447) | 4.43952544 |
| 28 | histone H4-K5 acetylation (GO:0043981) | 4.42906547 |
| 29 | histone H4-K8 acetylation (GO:0043982) | 4.42906547 |
| 30 | cytidine deamination (GO:0009972) | 4.39571695 |
| 31 | cytidine metabolic process (GO:0046087) | 4.39571695 |
| 32 | cytidine catabolic process (GO:0006216) | 4.39571695 |
| 33 | establishment of integrated proviral latency (GO:0075713) | 4.39180429 |
| 34 | nucleoside transmembrane transport (GO:1901642) | 4.38645098 |
| 35 | transepithelial transport (GO:0070633) | 4.35612152 |
| 36 | regulation of cilium movement (GO:0003352) | 4.31235513 |
| 37 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.28241192 |
| 38 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.27888309 |
| 39 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 4.20691793 |
| 40 | phenol-containing compound catabolic process (GO:0019336) | 4.20625536 |
| 41 | regulation of histone H3-K9 methylation (GO:0051570) | 4.15827071 |
| 42 | protein localization to chromosome, centromeric region (GO:0071459) | 4.13790968 |
| 43 | pre-miRNA processing (GO:0031054) | 4.10219055 |
| 44 | DNA duplex unwinding (GO:0032508) | 4.03917701 |
| 45 | negative regulation of telomerase activity (GO:0051974) | 4.01698941 |
| 46 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.98591461 |
| 47 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.97553179 |
| 48 | histone H4-K12 acetylation (GO:0043983) | 3.93999225 |
| 49 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.89340115 |
| 50 | DNA geometric change (GO:0032392) | 3.88393246 |
| 51 | intestinal epithelial cell development (GO:0060576) | 3.86858407 |
| 52 | primitive streak formation (GO:0090009) | 3.79417141 |
| 53 | rRNA transcription (GO:0009303) | 3.77227865 |
| 54 | cardiovascular system development (GO:0072358) | 3.76442791 |
| 55 | coenzyme catabolic process (GO:0009109) | 3.75854673 |
| 56 | bone trabecula formation (GO:0060346) | 3.73174765 |
| 57 | mitotic chromosome condensation (GO:0007076) | 3.72109830 |
| 58 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.66331200 |
| 59 | protein polyglutamylation (GO:0018095) | 3.64854816 |
| 60 | protein localization to kinetochore (GO:0034501) | 3.58468441 |
| 61 | DNA replication checkpoint (GO:0000076) | 3.54966297 |
| 62 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.54048721 |
| 63 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.52096609 |
| 64 | protein complex localization (GO:0031503) | 3.49923182 |
| 65 | mitotic metaphase plate congression (GO:0007080) | 3.49668773 |
| 66 | hypotonic response (GO:0006971) | 3.49075134 |
| 67 | icosanoid secretion (GO:0032309) | 3.47555813 |
| 68 | arachidonic acid secretion (GO:0050482) | 3.47555813 |
| 69 | DNA replication initiation (GO:0006270) | 3.45076466 |
| 70 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 3.42928818 |
| 71 | central nervous system myelination (GO:0022010) | 3.42921980 |
| 72 | axon ensheathment in central nervous system (GO:0032291) | 3.42921980 |
| 73 | mitochondrion distribution (GO:0048311) | 3.42760633 |
| 74 | histone H4-K16 acetylation (GO:0043984) | 3.41963193 |
| 75 | mitotic sister chromatid segregation (GO:0000070) | 3.41366536 |
| 76 | establishment of skin barrier (GO:0061436) | 3.39184265 |
| 77 | positive regulation of chromosome segregation (GO:0051984) | 3.39016009 |
| 78 | regulation of helicase activity (GO:0051095) | 3.38494261 |
| 79 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.37465863 |
| 80 | microtubule severing (GO:0051013) | 3.37418533 |
| 81 | negative regulation of DNA repair (GO:0045738) | 3.37276321 |
| 82 | mitotic nuclear envelope disassembly (GO:0007077) | 3.33313800 |
| 83 | paraxial mesoderm development (GO:0048339) | 3.31752752 |
| 84 | detection of temperature stimulus (GO:0016048) | 3.31747487 |
| 85 | nucleoside transport (GO:0015858) | 3.31263610 |
| 86 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.31099360 |
| 87 | establishment of viral latency (GO:0019043) | 3.29714532 |
| 88 | sister chromatid segregation (GO:0000819) | 3.29155906 |
| 89 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.29045679 |
| 90 | interferon-gamma production (GO:0032609) | 3.28412395 |
| 91 | negative regulation of histone methylation (GO:0031061) | 3.26657863 |
| 92 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.25533919 |
| 93 | positive regulation of macrophage cytokine production (GO:0060907) | 3.24749602 |
| 94 | proline transport (GO:0015824) | 3.21853958 |
| 95 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.21115101 |
| 96 | anterior/posterior axis specification (GO:0009948) | 3.18716083 |
| 97 | maintenance of protein localization in organelle (GO:0072595) | 3.18525438 |
| 98 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.18047809 |
| 99 | cellular protein complex localization (GO:0034629) | 3.17748029 |
| 100 | DNA strand renaturation (GO:0000733) | 3.17659765 |
| 101 | regulation of water loss via skin (GO:0033561) | 3.15379659 |
| 102 | negative regulation of cell fate commitment (GO:0010454) | 3.15323314 |
| 103 | regulation of sister chromatid cohesion (GO:0007063) | 3.14268106 |
| 104 | negative regulation of chromosome segregation (GO:0051985) | 3.13876564 |
| 105 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.12766471 |
| 106 | membrane disassembly (GO:0030397) | 3.12058084 |
| 107 | nuclear envelope disassembly (GO:0051081) | 3.12058084 |
| 108 | regulation of gene silencing (GO:0060968) | 3.11327034 |
| 109 | positive regulation of catenin import into nucleus (GO:0035413) | 3.11293777 |
| 110 | regulation of telomere maintenance (GO:0032204) | 3.11134771 |
| 111 | vitamin A metabolic process (GO:0006776) | 3.08817515 |
| 112 | quinone metabolic process (GO:1901661) | 3.08063919 |
| 113 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.08025992 |
| 114 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.07934237 |
| 115 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.07934237 |
| 116 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.07934237 |
| 117 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.07934237 |
| 118 | negative regulation of sister chromatid segregation (GO:0033046) | 3.07934237 |
| 119 | IMP biosynthetic process (GO:0006188) | 3.07265489 |
| 120 | ventricular system development (GO:0021591) | 3.07094547 |
| 121 | regulation of chromosome segregation (GO:0051983) | 3.06837406 |
| 122 | regulation of cell fate specification (GO:0042659) | 3.06483015 |
| 123 | negative regulation of viral release from host cell (GO:1902187) | 3.06465047 |
| 124 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.04696021 |
| 125 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.04696021 |
| 126 | DNA strand elongation (GO:0022616) | 3.03372332 |
| 127 | regulation of odontogenesis (GO:0042481) | 3.02887502 |
| 128 | L-serine metabolic process (GO:0006563) | 3.02792162 |
| 129 | regulation of translational fidelity (GO:0006450) | 3.02426543 |
| 130 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 3.02101555 |
| 131 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.00390014 |
| 132 | DNA conformation change (GO:0071103) | 2.99135657 |
| 133 | regulation of centriole replication (GO:0046599) | 2.97143250 |
| 134 | regulation of RNA export from nucleus (GO:0046831) | 2.96140877 |
| 135 | positive regulation of odontogenesis (GO:0042482) | 2.94991331 |
| 136 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.94166301 |
| 137 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.94166301 |
| 138 | regulation of sister chromatid segregation (GO:0033045) | 2.94166301 |
| 139 | regulation of microtubule-based movement (GO:0060632) | 2.92303280 |
| 140 | rRNA methylation (GO:0031167) | 2.92078061 |
| 141 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.91929251 |
| 142 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.91782201 |
| 143 | meiotic chromosome segregation (GO:0045132) | 2.91582041 |
| 144 | lateral sprouting from an epithelium (GO:0060601) | 2.91560227 |
| 145 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.90817215 |
| 146 | heterochromatin organization (GO:0070828) | 2.90128016 |
| 147 | regulation of cell fate commitment (GO:0010453) | 2.89366065 |
| 148 | embryonic axis specification (GO:0000578) | 2.88639420 |
| 149 | IMP metabolic process (GO:0046040) | 2.88587673 |
| 150 | omega-hydroxylase P450 pathway (GO:0097267) | 2.87612367 |
| 151 | hair follicle morphogenesis (GO:0031069) | 2.87598550 |
| 152 | chromatin assembly (GO:0031497) | 2.86419488 |
| 153 | myelin maintenance (GO:0043217) | 2.85965109 |
| 154 | retinoic acid receptor signaling pathway (GO:0048384) | 2.85939963 |
| 155 | regulation of DNA endoreduplication (GO:0032875) | 2.84497600 |
| 156 | mitotic spindle checkpoint (GO:0071174) | 2.84381529 |
| 157 | ovulation cycle (GO:0042698) | 2.84002222 |
| 158 | regulation of chromatin silencing (GO:0031935) | 2.83366276 |
| 159 | epoxygenase P450 pathway (GO:0019373) | 2.82968108 |
| 160 | ncRNA catabolic process (GO:0034661) | 2.81435459 |
| 161 | tachykinin receptor signaling pathway (GO:0007217) | 2.81167808 |
| 162 | establishment of endothelial barrier (GO:0061028) | 2.80487245 |
| 163 | regulation of centrosome cycle (GO:0046605) | 2.80294794 |
| 164 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.78955762 |
| 165 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.78901890 |
| 166 | positive regulation of protein deacetylation (GO:0090312) | 2.78321074 |
| 167 | spindle checkpoint (GO:0031577) | 2.77455727 |
| 168 | mitotic spindle assembly checkpoint (GO:0007094) | 2.77246814 |
| 169 | fatty acid derivative transport (GO:1901571) | 2.76453551 |
| 170 | icosanoid transport (GO:0071715) | 2.76453551 |
| 171 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.75865628 |
| 172 | response to X-ray (GO:0010165) | 2.75863810 |
| 173 | cellular modified amino acid catabolic process (GO:0042219) | 2.75521592 |
| 174 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.75315718 |
| 175 | regulation of stem cell maintenance (GO:2000036) | 2.72709755 |
| 176 | metaphase plate congression (GO:0051310) | 2.72583719 |
| 177 | nucleobase biosynthetic process (GO:0046112) | 2.70910006 |
| 178 | establishment of apical/basal cell polarity (GO:0035089) | 2.70736950 |
| 179 | hippo signaling (GO:0035329) | 2.70299145 |
| 180 | inner cell mass cell proliferation (GO:0001833) | 2.69776235 |
| 181 | spindle assembly checkpoint (GO:0071173) | 2.69462562 |
| 182 | histone phosphorylation (GO:0016572) | 2.68775350 |
| 183 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.67432103 |
| 184 | nuclear envelope organization (GO:0006998) | 2.67204217 |
| 185 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.66897263 |
| 186 | non-recombinational repair (GO:0000726) | 2.66897263 |
| 187 | regulation of centrosome duplication (GO:0010824) | 2.66181665 |
| 188 | embryonic process involved in female pregnancy (GO:0060136) | 2.64985506 |
| 189 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.63026589 |
| 190 | histone-serine phosphorylation (GO:0035404) | 2.62234275 |
| 191 | DNA synthesis involved in DNA repair (GO:0000731) | 2.61002249 |
| 192 | lung-associated mesenchyme development (GO:0060484) | 2.60621565 |
| 193 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.60513371 |
| 194 | mesodermal cell differentiation (GO:0048333) | 2.60494230 |
| 195 | CENP-A containing nucleosome assembly (GO:0034080) | 2.59201695 |
| 196 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.57179295 |
| 197 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.57179295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.55794860 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.93684591 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.93684591 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.93684591 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.81436660 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.52802680 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.39447557 |
| 8 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.31739531 |
| 9 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.19453172 |
| 10 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 3.15532352 |
| 11 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 3.02522927 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.95753687 |
| 13 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.68446914 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.59663718 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58397491 |
| 16 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.56438260 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.54023811 |
| 18 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.52361591 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.49146517 |
| 20 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.44028686 |
| 21 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.39383499 |
| 22 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 2.26488266 |
| 23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.20320012 |
| 24 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.18859403 |
| 25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.18312517 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18037336 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.17052930 |
| 28 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.11774941 |
| 29 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.09261452 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.02452234 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01103621 |
| 32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.99311076 |
| 33 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.92101778 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.90875365 |
| 35 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.86530171 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.86269964 |
| 37 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.85499387 |
| 38 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.81219304 |
| 39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.80027457 |
| 40 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.78218750 |
| 41 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78051884 |
| 42 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.76554818 |
| 43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.73864900 |
| 44 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.73293663 |
| 45 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.72189249 |
| 46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.67808413 |
| 47 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.67771515 |
| 48 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.66085648 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.64984185 |
| 50 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.64292264 |
| 51 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.64151460 |
| 52 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.62212810 |
| 53 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.61458136 |
| 54 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.60132192 |
| 55 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.59273697 |
| 56 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.55832539 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54309174 |
| 58 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.54142090 |
| 59 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.52611765 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.52323399 |
| 61 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.48102086 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46955827 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.45290610 |
| 64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45233700 |
| 65 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.43829123 |
| 66 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.43637389 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41210514 |
| 68 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40909555 |
| 69 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.39629071 |
| 70 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39452400 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37354319 |
| 72 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.31577428 |
| 73 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.31553595 |
| 74 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.30393627 |
| 75 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.30393627 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.29454744 |
| 77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28940087 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28386625 |
| 79 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.28097730 |
| 80 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.27991382 |
| 81 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.27367914 |
| 82 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.25466295 |
| 83 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.24440350 |
| 84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24292552 |
| 85 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.23672168 |
| 86 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23219575 |
| 87 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23069201 |
| 88 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.22565083 |
| 89 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22457238 |
| 90 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.21639885 |
| 91 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.20493651 |
| 92 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20115326 |
| 93 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19500808 |
| 94 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.18954581 |
| 95 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.18764551 |
| 96 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18050710 |
| 97 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17819002 |
| 98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17043533 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16058075 |
| 100 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.14986012 |
| 101 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.14945137 |
| 102 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.14873181 |
| 103 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.13922985 |
| 104 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11767823 |
| 105 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11204212 |
| 106 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09140733 |
| 107 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.09107830 |
| 108 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.08292882 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08169852 |
| 110 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.08148216 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07529595 |
| 112 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.07521569 |
| 113 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.06933031 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06827436 |
| 115 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.06055274 |
| 116 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05862255 |
| 117 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.05093307 |
| 118 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04934735 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04357121 |
| 120 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03195913 |
| 121 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02545546 |
| 122 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.01972924 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01306252 |
| 124 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01289248 |
| 125 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00642523 |
| 126 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00306027 |
| 127 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.00078218 |
| 128 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99602510 |
| 129 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98790997 |
| 130 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98687693 |
| 131 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.98638699 |
| 132 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97957716 |
| 133 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97697651 |
| 134 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97400430 |
| 135 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97049498 |
| 136 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95535728 |
| 137 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.95423650 |
| 138 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94685850 |
| 139 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94504199 |
| 140 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.94405070 |
| 141 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.94351244 |
| 142 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94267091 |
| 143 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94109176 |
| 144 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91588286 |
| 145 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.91562082 |
| 146 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91288465 |
| 147 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.90959058 |
| 148 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90956584 |
| 149 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90762332 |
| 150 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.90633186 |
| 151 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90477812 |
| 152 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90477812 |
| 153 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89617107 |
| 154 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89505497 |
| 155 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89115011 |
| 156 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88479975 |
| 157 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.88256558 |
| 158 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.87454923 |
| 159 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86395589 |
| 160 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.85338737 |
| 161 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.85049601 |
| 162 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81323550 |
| 163 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.80955433 |
| 164 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.80041263 |
| 165 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.79167169 |
| 166 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78426404 |
| 167 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77564311 |
| 168 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.76312354 |
| 169 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.75643878 |
| 170 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.74576492 |
| 171 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.74385140 |
| 172 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.72993352 |
| 173 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.72654607 |
| 174 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.71826441 |
| 175 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71826441 |
| 176 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.71713938 |
| 177 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.71445515 |
| 178 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.71160234 |
| 179 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.70608803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 7.42045666 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 4.34959905 |
| 3 | MP0003011_delayed_dark_adaptation | 3.85032331 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.84818792 |
| 5 | MP0005499_abnormal_olfactory_system | 3.39441806 |
| 6 | MP0005394_taste/olfaction_phenotype | 3.39441806 |
| 7 | MP0006292_abnormal_olfactory_placode | 3.34605181 |
| 8 | MP0010094_abnormal_chromosome_stability | 3.23245877 |
| 9 | MP0003111_abnormal_nucleus_morphology | 3.18786700 |
| 10 | MP0003941_abnormal_skin_development | 3.16111922 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 3.05254182 |
| 12 | MP0005075_abnormal_melanosome_morpholog | 2.85358908 |
| 13 | MP0004858_abnormal_nervous_system | 2.71373078 |
| 14 | MP0003077_abnormal_cell_cycle | 2.68064366 |
| 15 | MP0008007_abnormal_cellular_replicative | 2.50935927 |
| 16 | MP0010678_abnormal_skin_adnexa | 2.47621639 |
| 17 | MP0000383_abnormal_hair_follicle | 2.46156391 |
| 18 | MP0000762_abnormal_tongue_morphology | 2.28516747 |
| 19 | MP0001849_ear_inflammation | 2.25574435 |
| 20 | MP0002098_abnormal_vibrissa_morphology | 2.24312983 |
| 21 | MP0001730_embryonic_growth_arrest | 2.22826895 |
| 22 | MP0004381_abnormal_hair_follicle | 2.17560586 |
| 23 | MP0002796_impaired_skin_barrier | 2.16123306 |
| 24 | MP0003566_abnormal_cell_adhesion | 2.13019287 |
| 25 | MP0003718_maternal_effect | 2.12085356 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 2.05325235 |
| 27 | MP0003122_maternal_imprinting | 2.05243372 |
| 28 | MP0003938_abnormal_ear_development | 2.03125629 |
| 29 | MP0002332_abnormal_exercise_endurance | 2.03111274 |
| 30 | MP0005076_abnormal_cell_differentiation | 2.01757985 |
| 31 | MP0010307_abnormal_tumor_latency | 1.99951094 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.97002970 |
| 33 | MP0000678_abnormal_parathyroid_gland | 1.92607907 |
| 34 | MP0008057_abnormal_DNA_replication | 1.90927914 |
| 35 | MP0008932_abnormal_embryonic_tissue | 1.89803428 |
| 36 | MP0001348_abnormal_lacrimal_gland | 1.83078524 |
| 37 | MP0008789_abnormal_olfactory_epithelium | 1.77656067 |
| 38 | MP0008058_abnormal_DNA_repair | 1.74946130 |
| 39 | MP0010030_abnormal_orbit_morphology | 1.66264666 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.62925219 |
| 41 | MP0002233_abnormal_nose_morphology | 1.61148908 |
| 42 | MP0000647_abnormal_sebaceous_gland | 1.61020759 |
| 43 | MP0001346_abnormal_lacrimal_gland | 1.60419417 |
| 44 | MP0001697_abnormal_embryo_size | 1.60132100 |
| 45 | MP0003950_abnormal_plasma_membrane | 1.57674103 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.54524860 |
| 47 | MP0000049_abnormal_middle_ear | 1.52967657 |
| 48 | MP0009672_abnormal_birth_weight | 1.52112168 |
| 49 | MP0002009_preneoplasia | 1.48467592 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.47412558 |
| 51 | MP0002932_abnormal_joint_morphology | 1.46700112 |
| 52 | MP0002006_tumorigenesis | 1.45687685 |
| 53 | MP0002080_prenatal_lethality | 1.44742318 |
| 54 | MP0000377_abnormal_hair_follicle | 1.44703457 |
| 55 | MP0000579_abnormal_nail_morphology | 1.42125466 |
| 56 | MP0000537_abnormal_urethra_morphology | 1.40367254 |
| 57 | MP0003121_genomic_imprinting | 1.39235458 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.38703599 |
| 59 | MP0000490_abnormal_crypts_of | 1.37849674 |
| 60 | MP0002092_abnormal_eye_morphology | 1.37780011 |
| 61 | MP0009697_abnormal_copulation | 1.35803837 |
| 62 | MP0004197_abnormal_fetal_growth/weight/ | 1.35162779 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.31683445 |
| 64 | MP0003755_abnormal_palate_morphology | 1.30344949 |
| 65 | MP0005248_abnormal_Harderian_gland | 1.30039714 |
| 66 | MP0001293_anophthalmia | 1.29008692 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.24926024 |
| 68 | MP0004885_abnormal_endolymph | 1.20851340 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.20237281 |
| 70 | MP0003937_abnormal_limbs/digits/tail_de | 1.19322068 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.18280559 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.18051217 |
| 73 | MP0000432_abnormal_head_morphology | 1.16761138 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 1.15910173 |
| 75 | MP0002396_abnormal_hematopoietic_system | 1.13528855 |
| 76 | MP0000313_abnormal_cell_death | 1.10808239 |
| 77 | MP0003448_altered_tumor_morphology | 1.08023122 |
| 78 | MP0005621_abnormal_cell_physiology | 1.07496739 |
| 79 | MP0003935_abnormal_craniofacial_develop | 1.05831677 |
| 80 | MP0003091_abnormal_cell_migration | 1.03383726 |
| 81 | MP0002019_abnormal_tumor_incidence | 1.02601234 |
| 82 | MP0004233_abnormal_muscle_weight | 1.02434014 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 1.02150181 |
| 84 | MP0002127_abnormal_cardiovascular_syste | 1.01613656 |
| 85 | MP0006082_CNS_inflammation | 1.00782216 |
| 86 | MP0000428_abnormal_craniofacial_morphol | 1.00386783 |
| 87 | MP0003045_fibrosis | 1.00216062 |
| 88 | MP0002697_abnormal_eye_size | 1.00180010 |
| 89 | MP0000920_abnormal_myelination | 0.99722280 |
| 90 | MP0005501_abnormal_skin_physiology | 0.99390948 |
| 91 | MP0002114_abnormal_axial_skeleton | 0.98446653 |
| 92 | MP0004272_abnormal_basement_membrane | 0.97705974 |
| 93 | MP0003315_abnormal_perineum_morphology | 0.96365017 |
| 94 | MP0002249_abnormal_larynx_morphology | 0.94835227 |
| 95 | MP0001661_extended_life_span | 0.94659668 |
| 96 | MP0000467_abnormal_esophagus_morphology | 0.94313069 |
| 97 | MP0001188_hyperpigmentation | 0.94287890 |
| 98 | MP0002060_abnormal_skin_morphology | 0.93893610 |
| 99 | MP0001672_abnormal_embryogenesis/_devel | 0.93892673 |
| 100 | MP0005380_embryogenesis_phenotype | 0.93892673 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.93769715 |
| 102 | MP0001915_intracranial_hemorrhage | 0.93733193 |
| 103 | MP0000613_abnormal_salivary_gland | 0.92607441 |
| 104 | MP0003806_abnormal_nucleotide_metabolis | 0.92401959 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.92256642 |
| 106 | MP0005310_abnormal_salivary_gland | 0.92195410 |
| 107 | MP0004133_heterotaxia | 0.91177730 |
| 108 | MP0004043_abnormal_pH_regulation | 0.90936700 |
| 109 | MP0009703_decreased_birth_body | 0.88124084 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.88062166 |
| 111 | MP0005508_abnormal_skeleton_morphology | 0.88045144 |
| 112 | MP0000858_altered_metastatic_potential | 0.87758141 |
| 113 | MP0005391_vision/eye_phenotype | 0.85769612 |
| 114 | MP0002088_abnormal_embryonic_growth/wei | 0.85255875 |
| 115 | MP0001216_abnormal_epidermal_layer | 0.84261435 |
| 116 | MP0005384_cellular_phenotype | 0.83389889 |
| 117 | MP0003984_embryonic_growth_retardation | 0.82205457 |
| 118 | MP0002116_abnormal_craniofacial_bone | 0.81550850 |
| 119 | MP0005395_other_phenotype | 0.80645475 |
| 120 | MP0008877_abnormal_DNA_methylation | 0.80362358 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.80220342 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.79676489 |
| 123 | MP0000778_abnormal_nervous_system | 0.79583565 |
| 124 | MP0004947_skin_inflammation | 0.79430647 |
| 125 | MP0005083_abnormal_biliary_tract | 0.79249153 |
| 126 | MP0000358_abnormal_cell_content/ | 0.78871714 |
| 127 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78480864 |
| 128 | MP0000477_abnormal_intestine_morphology | 0.78016437 |
| 129 | MP0009250_abnormal_appendicular_skeleto | 0.77230951 |
| 130 | MP0001191_abnormal_skin_condition | 0.77167911 |
| 131 | MP0003763_abnormal_thymus_physiology | 0.77142398 |
| 132 | MP0000427_abnormal_hair_cycle | 0.76995905 |
| 133 | MP0002085_abnormal_embryonic_tissue | 0.73964405 |
| 134 | MP0003136_yellow_coat_color | 0.73783369 |
| 135 | MP0002751_abnormal_autonomic_nervous | 0.73196854 |
| 136 | MP0010771_integument_phenotype | 0.71201106 |
| 137 | MP0000627_abnormal_mammary_gland | 0.70117448 |
| 138 | MP0003119_abnormal_digestive_system | 0.68811806 |
| 139 | MP0002752_abnormal_somatic_nervous | 0.67878578 |
| 140 | MP0000462_abnormal_digestive_system | 0.67540327 |
| 141 | MP0008770_decreased_survivor_rate | 0.67246051 |
| 142 | MP0005023_abnormal_wound_healing | 0.67138922 |
| 143 | MP0002925_abnormal_cardiovascular_devel | 0.64778757 |
| 144 | MP0001486_abnormal_startle_reflex | 0.64171382 |
| 145 | MP0004957_abnormal_blastocyst_morpholog | 0.62787618 |
| 146 | MP0005409_darkened_coat_color | 0.62215248 |
| 147 | MP0009278_abnormal_bone_marrow | 0.61746727 |
| 148 | MP0002084_abnormal_developmental_patter | 0.61516908 |
| 149 | MP0002086_abnormal_extraembryonic_tissu | 0.59616504 |
| 150 | MP0001270_distended_abdomen | 0.59603015 |
| 151 | MP0004782_abnormal_surfactant_physiolog | 0.59591298 |
| 152 | MP0004185_abnormal_adipocyte_glucose | 0.58865206 |
| 153 | MP0005275_abnormal_skin_tensile | 0.58848345 |
| 154 | MP0003828_pulmonary_edema | 0.58280615 |
| 155 | MP0003699_abnormal_female_reproductive | 0.58192533 |
| 156 | MP0002081_perinatal_lethality | 0.57794329 |
| 157 | MP0005197_abnormal_uvea_morphology | 0.55965966 |
| 158 | MP0002111_abnormal_tail_morphology | 0.55813336 |
| 159 | MP0000350_abnormal_cell_proliferation | 0.55812896 |
| 160 | MP0003861_abnormal_nervous_system | 0.55735743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.24616763 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.67469876 |
| 3 | Hepatoblastoma (HP:0002884) | 5.19807945 |
| 4 | Poikiloderma (HP:0001029) | 4.62807238 |
| 5 | Abnormality of the intrinsic pathway (HP:0010989) | 4.07900768 |
| 6 | Rib fusion (HP:0000902) | 4.04888900 |
| 7 | Sensory axonal neuropathy (HP:0003390) | 3.58639502 |
| 8 | Ependymoma (HP:0002888) | 3.57806404 |
| 9 | Abnormality of the salivary glands (HP:0010286) | 3.54454203 |
| 10 | Hypoplasia of the fovea (HP:0007750) | 3.53722223 |
| 11 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.53722223 |
| 12 | Nasolacrimal duct obstruction (HP:0000579) | 3.53205525 |
| 13 | Preauricular pit (HP:0004467) | 3.48849124 |
| 14 | Periauricular skin pits (HP:0100277) | 3.48849124 |
| 15 | Abnormality of the astrocytes (HP:0100707) | 3.46591803 |
| 16 | Astrocytoma (HP:0009592) | 3.46591803 |
| 17 | Anomalous pulmonary venous return (HP:0010772) | 3.44961722 |
| 18 | Abnormality of the lower motor neuron (HP:0002366) | 3.42139654 |
| 19 | Partial duplication of thumb phalanx (HP:0009944) | 3.40808848 |
| 20 | Birth length less than 3rd percentile (HP:0003561) | 3.40019850 |
| 21 | Multiple enchondromatosis (HP:0005701) | 3.38209967 |
| 22 | Neoplasm of striated muscle (HP:0009728) | 3.33985385 |
| 23 | Reduced antithrombin III activity (HP:0001976) | 3.17386072 |
| 24 | Fused cervical vertebrae (HP:0002949) | 3.17215303 |
| 25 | Gastrointestinal carcinoma (HP:0002672) | 3.09229649 |
| 26 | Malignant gastrointestinal tract tumors (HP:0006749) | 3.09229649 |
| 27 | Rectovaginal fistula (HP:0000143) | 2.98460440 |
| 28 | Rectal fistula (HP:0100590) | 2.98460440 |
| 29 | Rhabdomyosarcoma (HP:0002859) | 2.97869798 |
| 30 | Selective tooth agenesis (HP:0001592) | 2.95652689 |
| 31 | Abnormality of the pulmonary veins (HP:0011718) | 2.91670870 |
| 32 | Partial duplication of the phalanx of hand (HP:0009999) | 2.90129364 |
| 33 | Absent radius (HP:0003974) | 2.90053231 |
| 34 | Skin pits (HP:0100276) | 2.87995031 |
| 35 | Bifid tongue (HP:0010297) | 2.84780247 |
| 36 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.82382017 |
| 37 | Capillary hemangiomas (HP:0005306) | 2.81942294 |
| 38 | Lip pit (HP:0100267) | 2.81813882 |
| 39 | Ankyloglossia (HP:0010296) | 2.80253385 |
| 40 | Biliary tract neoplasm (HP:0100574) | 2.79817062 |
| 41 | Spastic diplegia (HP:0001264) | 2.79638854 |
| 42 | Intestinal fistula (HP:0100819) | 2.78828129 |
| 43 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.77014158 |
| 44 | Dyschromatopsia (HP:0007641) | 2.73756809 |
| 45 | Progressive external ophthalmoplegia (HP:0000590) | 2.71753134 |
| 46 | Abnormality of the lacrimal duct (HP:0011481) | 2.71581855 |
| 47 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.71358163 |
| 48 | Villous atrophy (HP:0011473) | 2.63428534 |
| 49 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.63428534 |
| 50 | Aplasia involving forearm bones (HP:0009822) | 2.63150992 |
| 51 | Absent forearm bone (HP:0003953) | 2.63150992 |
| 52 | Abnormality of the fovea (HP:0000493) | 2.63147854 |
| 53 | Abnormality of the corticospinal tract (HP:0002492) | 2.62789744 |
| 54 | Large earlobe (HP:0009748) | 2.61742624 |
| 55 | Embryonal renal neoplasm (HP:0011794) | 2.60496867 |
| 56 | Squamous cell carcinoma (HP:0002860) | 2.60063422 |
| 57 | Vaginal fistula (HP:0004320) | 2.55296495 |
| 58 | Glioma (HP:0009733) | 2.49587145 |
| 59 | Ulnar bowing (HP:0003031) | 2.47714953 |
| 60 | Abnormality of oral frenula (HP:0000190) | 2.47034399 |
| 61 | Basal cell carcinoma (HP:0002671) | 2.46778609 |
| 62 | Abnormality of the preputium (HP:0100587) | 2.46328732 |
| 63 | Uterine neoplasm (HP:0010784) | 2.45740181 |
| 64 | Deviation of the thumb (HP:0009603) | 2.45705236 |
| 65 | Preauricular skin tag (HP:0000384) | 2.45112291 |
| 66 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.41833556 |
| 67 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.41562453 |
| 68 | Uterine leiomyosarcoma (HP:0002891) | 2.39798649 |
| 69 | Leiomyosarcoma (HP:0100243) | 2.39798649 |
| 70 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.38956430 |
| 71 | Short humerus (HP:0005792) | 2.38878102 |
| 72 | Abnormality of chromosome stability (HP:0003220) | 2.37828310 |
| 73 | Generalized hypotonia (HP:0001290) | 2.36702436 |
| 74 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.36472405 |
| 75 | Abnormality of chromosome segregation (HP:0002916) | 2.36176484 |
| 76 | Difficulty running (HP:0009046) | 2.35875698 |
| 77 | Type I transferrin isoform profile (HP:0003642) | 2.35540216 |
| 78 | Abnormality of the pubic bones (HP:0003172) | 2.34393101 |
| 79 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.31409914 |
| 80 | Trismus (HP:0000211) | 2.30841693 |
| 81 | Skull defect (HP:0001362) | 2.30693753 |
| 82 | Abnormal lung lobation (HP:0002101) | 2.30667806 |
| 83 | Abnormality of the nasolacrimal system (HP:0000614) | 2.29336275 |
| 84 | Testicular atrophy (HP:0000029) | 2.29108675 |
| 85 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.28260005 |
| 86 | Turricephaly (HP:0000262) | 2.28024561 |
| 87 | Hyperventilation (HP:0002883) | 2.27490373 |
| 88 | Neoplasm of the heart (HP:0100544) | 2.27241646 |
| 89 | Amyotrophic lateral sclerosis (HP:0007354) | 2.22801152 |
| 90 | Abnormal auditory evoked potentials (HP:0006958) | 2.20213046 |
| 91 | Choanal stenosis (HP:0000452) | 2.19439977 |
| 92 | Upper limb muscle weakness (HP:0003484) | 2.18767539 |
| 93 | Chromsome breakage (HP:0040012) | 2.18553063 |
| 94 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.18479699 |
| 95 | Stenosis of the external auditory canal (HP:0000402) | 2.17650453 |
| 96 | Skin tags (HP:0010609) | 2.17099403 |
| 97 | Abnormality of cochlea (HP:0000375) | 2.16807630 |
| 98 | Short chin (HP:0000331) | 2.16142179 |
| 99 | Prominent occiput (HP:0000269) | 2.14438651 |
| 100 | IgA deficiency (HP:0002720) | 2.13766392 |
| 101 | Horizontal nystagmus (HP:0000666) | 2.13495414 |
| 102 | Bladder carcinoma (HP:0002862) | 2.10907360 |
| 103 | Bladder neoplasm (HP:0009725) | 2.10907360 |
| 104 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.10220808 |
| 105 | Difficulty walking (HP:0002355) | 2.09128304 |
| 106 | Curly hair (HP:0002212) | 2.07859019 |
| 107 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.06370282 |
| 108 | Hypopigmentation of the fundus (HP:0007894) | 2.05337615 |
| 109 | Progressive muscle weakness (HP:0003323) | 2.04095024 |
| 110 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.03879919 |
| 111 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.03879919 |
| 112 | Abnormal protein glycosylation (HP:0012346) | 2.03879919 |
| 113 | Abnormal glycosylation (HP:0012345) | 2.03879919 |
| 114 | Abnormality of the musculature of the hand (HP:0001421) | 2.02925593 |
| 115 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.02191844 |
| 116 | Hypoplastic scapulae (HP:0000882) | 2.02191844 |
| 117 | Increased nuchal translucency (HP:0010880) | 2.02032926 |
| 118 | Proximal placement of thumb (HP:0009623) | 1.99325801 |
| 119 | Neoplasm of the small intestine (HP:0100833) | 1.97214812 |
| 120 | Spastic tetraparesis (HP:0001285) | 1.96494327 |
| 121 | Morphological abnormality of the inner ear (HP:0011390) | 1.96439881 |
| 122 | Hypoplasia of the pons (HP:0012110) | 1.96294862 |
| 123 | Myelodysplasia (HP:0002863) | 1.95874686 |
| 124 | Supernumerary nipples (HP:0002558) | 1.95597221 |
| 125 | Deep philtrum (HP:0002002) | 1.95505523 |
| 126 | Entropion (HP:0000621) | 1.95024847 |
| 127 | Neoplasm of the colon (HP:0100273) | 1.93776065 |
| 128 | Prominent nose (HP:0000448) | 1.91379748 |
| 129 | Duplication of thumb phalanx (HP:0009942) | 1.90143657 |
| 130 | Hypotrichosis (HP:0001006) | 1.90115328 |
| 131 | Facial hemangioma (HP:0000329) | 1.90060020 |
| 132 | Wide nose (HP:0000445) | 1.89867982 |
| 133 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89351465 |
| 134 | Osteolytic defects of the hand bones (HP:0009699) | 1.89351465 |
| 135 | Tracheal stenosis (HP:0002777) | 1.88556099 |
| 136 | Broad face (HP:0000283) | 1.87343424 |
| 137 | Vertebral fusion (HP:0002948) | 1.86881438 |
| 138 | Supernumerary ribs (HP:0005815) | 1.86334708 |
| 139 | Open mouth (HP:0000194) | 1.85252135 |
| 140 | Premature loss of primary teeth (HP:0006323) | 1.84660551 |
| 141 | Breast aplasia (HP:0100783) | 1.84257361 |
| 142 | Shawl scrotum (HP:0000049) | 1.83831965 |
| 143 | Aplasia cutis congenita (HP:0001057) | 1.83579152 |
| 144 | Breast hypoplasia (HP:0003187) | 1.83088378 |
| 145 | Short 5th finger (HP:0009237) | 1.82876074 |
| 146 | Preaxial foot polydactyly (HP:0001841) | 1.82420915 |
| 147 | Abnormality of nail color (HP:0100643) | 1.82137866 |
| 148 | Ragged-red muscle fibers (HP:0003200) | 1.82086023 |
| 149 | Abnormal biliary tract morphology (HP:0012440) | 1.81887040 |
| 150 | Meckel diverticulum (HP:0002245) | 1.80002673 |
| 151 | Abnormality of the pons (HP:0007361) | 1.79686787 |
| 152 | Neoplasm of the rectum (HP:0100743) | 1.79131986 |
| 153 | Colon cancer (HP:0003003) | 1.78733290 |
| 154 | Tongue fasciculations (HP:0001308) | 1.78471084 |
| 155 | Amniotic constriction ring (HP:0009775) | 1.78290258 |
| 156 | Abnormality of placental membranes (HP:0011409) | 1.78290258 |
| 157 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.78075264 |
| 158 | Right ventricular cardiomyopathy (HP:0011663) | 1.77975911 |
| 159 | Periodontitis (HP:0000704) | 1.77810382 |
| 160 | Acute myeloid leukemia (HP:0004808) | 1.77801560 |
| 161 | Small intestinal stenosis (HP:0012848) | 1.77308526 |
| 162 | Duodenal stenosis (HP:0100867) | 1.77308526 |
| 163 | Abnormal cartilage morphology (HP:0002763) | 1.76957132 |
| 164 | Neoplasm of the oral cavity (HP:0100649) | 1.76784005 |
| 165 | Abnormality of homocysteine metabolism (HP:0010919) | 1.75671111 |
| 166 | Homocystinuria (HP:0002156) | 1.75671111 |
| 167 | Glossoptosis (HP:0000162) | 1.75495734 |
| 168 | Ventricular tachycardia (HP:0004756) | 1.74404167 |
| 169 | Subacute progressive viral hepatitis (HP:0006572) | 1.74386319 |
| 170 | Neoplasm of the pancreas (HP:0002894) | 1.73860850 |
| 171 | Cheilitis (HP:0100825) | 1.73474626 |
| 172 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73403750 |
| 173 | Coronal craniosynostosis (HP:0004440) | 1.72064544 |
| 174 | Diastasis recti (HP:0001540) | 1.72063663 |
| 175 | Pseudobulbar signs (HP:0002200) | 1.71469178 |
| 176 | Tented upper lip vermilion (HP:0010804) | 1.70716289 |
| 177 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.70125541 |
| 178 | Abnormality of glycolipid metabolism (HP:0010969) | 1.69652669 |
| 179 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.69652669 |
| 180 | Abnormality of the common coagulation pathway (HP:0010990) | 1.69228656 |
| 181 | Renal cell carcinoma (HP:0005584) | 1.68345954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.56879207 |
| 2 | GRK5 | 4.89156035 |
| 3 | ERN1 | 3.62391320 |
| 4 | GRK6 | 3.43737482 |
| 5 | GRK1 | 3.01178222 |
| 6 | MST1R | 2.96974764 |
| 7 | TYRO3 | 2.87062914 |
| 8 | ADRBK2 | 2.78211781 |
| 9 | PBK | 2.76678448 |
| 10 | BUB1 | 2.70963064 |
| 11 | WNK1 | 2.50361263 |
| 12 | GRK7 | 2.48736719 |
| 13 | SMG1 | 2.46760893 |
| 14 | CSF1R | 2.45305399 |
| 15 | BRD4 | 2.40622564 |
| 16 | ERBB4 | 2.39360873 |
| 17 | CDC7 | 2.37292316 |
| 18 | EPHA2 | 2.36481047 |
| 19 | BRSK2 | 2.27709522 |
| 20 | TGFBR2 | 2.21166825 |
| 21 | TSSK6 | 2.13315224 |
| 22 | MAPK7 | 2.11809463 |
| 23 | MKNK2 | 2.03010167 |
| 24 | NTRK1 | 2.02639776 |
| 25 | TAF1 | 1.98124703 |
| 26 | MATK | 1.94700638 |
| 27 | EPHB1 | 1.81018012 |
| 28 | ACVR1B | 1.80655603 |
| 29 | STK10 | 1.78803717 |
| 30 | MOS | 1.73851998 |
| 31 | LATS1 | 1.71683563 |
| 32 | SRPK1 | 1.71469152 |
| 33 | MARK2 | 1.69457714 |
| 34 | STK39 | 1.66809268 |
| 35 | TTK | 1.60302998 |
| 36 | STK3 | 1.55382917 |
| 37 | NME2 | 1.52188095 |
| 38 | STK38L | 1.47625237 |
| 39 | PLK3 | 1.44509112 |
| 40 | MKNK1 | 1.42398742 |
| 41 | EIF2AK3 | 1.33455701 |
| 42 | MELK | 1.33101297 |
| 43 | CAMK4 | 1.32564768 |
| 44 | FGFR4 | 1.30459527 |
| 45 | PRPF4B | 1.30159214 |
| 46 | SCYL2 | 1.29960532 |
| 47 | HIPK2 | 1.29142931 |
| 48 | PLK4 | 1.25974876 |
| 49 | IRAK3 | 1.25627677 |
| 50 | FGFR3 | 1.23996049 |
| 51 | PRKG2 | 1.23150049 |
| 52 | WEE1 | 1.22764590 |
| 53 | BCR | 1.21314058 |
| 54 | NEK2 | 1.16845283 |
| 55 | CDK6 | 1.14388245 |
| 56 | MAP3K14 | 1.14269250 |
| 57 | STK24 | 1.13052393 |
| 58 | MST4 | 1.10347175 |
| 59 | VRK2 | 1.09215602 |
| 60 | TRIM28 | 1.08922341 |
| 61 | ZAK | 1.07946050 |
| 62 | PKN1 | 1.05088629 |
| 63 | ADRBK1 | 1.04927827 |
| 64 | CAMK1D | 1.00155475 |
| 65 | BMX | 0.97762272 |
| 66 | PDGFRA | 0.97574066 |
| 67 | CDK4 | 0.96436964 |
| 68 | FGFR1 | 0.91076221 |
| 69 | TTN | 0.89458675 |
| 70 | MAP3K7 | 0.89377917 |
| 71 | ATR | 0.86202759 |
| 72 | PTK2 | 0.85980450 |
| 73 | CDK7 | 0.83673927 |
| 74 | DDR2 | 0.82257536 |
| 75 | PAK4 | 0.81923198 |
| 76 | OXSR1 | 0.81806074 |
| 77 | CDK9 | 0.81691769 |
| 78 | MAP3K9 | 0.81649002 |
| 79 | ERBB2 | 0.80876872 |
| 80 | PDK2 | 0.79564374 |
| 81 | AURKB | 0.78812026 |
| 82 | EEF2K | 0.76626455 |
| 83 | CDK8 | 0.76144611 |
| 84 | STK4 | 0.74299588 |
| 85 | PAK3 | 0.73624424 |
| 86 | EIF2AK1 | 0.73028718 |
| 87 | CHEK2 | 0.71170965 |
| 88 | ATM | 0.70290270 |
| 89 | MAP3K13 | 0.67919440 |
| 90 | MAPK12 | 0.66231471 |
| 91 | AKT3 | 0.65693522 |
| 92 | CSNK1A1L | 0.65238333 |
| 93 | YES1 | 0.64205099 |
| 94 | CSK | 0.64165086 |
| 95 | NEK1 | 0.63002443 |
| 96 | DYRK2 | 0.62519723 |
| 97 | NUAK1 | 0.62111461 |
| 98 | MAP3K8 | 0.61699462 |
| 99 | LMTK2 | 0.61047457 |
| 100 | EIF2AK2 | 0.59277019 |
| 101 | RPS6KB2 | 0.59013318 |
| 102 | MAPKAPK3 | 0.58708110 |
| 103 | BRSK1 | 0.57633186 |
| 104 | VRK1 | 0.56896989 |
| 105 | PAK6 | 0.56702844 |
| 106 | MAP2K4 | 0.56386056 |
| 107 | MET | 0.55164679 |
| 108 | SIK3 | 0.54312469 |
| 109 | AKT2 | 0.53308123 |
| 110 | SIK1 | 0.52645916 |
| 111 | PIM1 | 0.51369362 |
| 112 | IRAK2 | 0.50652824 |
| 113 | CLK1 | 0.50412305 |
| 114 | MTOR | 0.50022972 |
| 115 | FLT3 | 0.48757688 |
| 116 | NLK | 0.48460918 |
| 117 | DMPK | 0.47019383 |
| 118 | CDK1 | 0.46429696 |
| 119 | ITK | 0.46385834 |
| 120 | FGFR2 | 0.46137698 |
| 121 | ALK | 0.45745010 |
| 122 | TIE1 | 0.45339182 |
| 123 | CDK2 | 0.44959380 |
| 124 | MAP2K6 | 0.44262660 |
| 125 | GSK3A | 0.43609220 |
| 126 | CSNK1G3 | 0.42548417 |
| 127 | FER | 0.42281843 |
| 128 | DYRK1A | 0.41927901 |
| 129 | ICK | 0.41587115 |
| 130 | TGFBR1 | 0.40948850 |
| 131 | EPHA3 | 0.40649535 |
| 132 | CHUK | 0.40271312 |
| 133 | PRKCI | 0.38623056 |
| 134 | INSR | 0.38181362 |
| 135 | CHEK1 | 0.37934043 |
| 136 | IGF1R | 0.35924807 |
| 137 | MAP3K10 | 0.35246078 |
| 138 | IKBKB | 0.34608491 |
| 139 | EPHB2 | 0.33793828 |
| 140 | MAPK10 | 0.33314626 |
| 141 | LATS2 | 0.33182284 |
| 142 | MAP2K3 | 0.32741611 |
| 143 | EGFR | 0.31704732 |
| 144 | CSNK1E | 0.31588319 |
| 145 | TESK2 | 0.31579371 |
| 146 | NEK6 | 0.31537335 |
| 147 | AURKA | 0.31021561 |
| 148 | JAK3 | 0.30833832 |
| 149 | DYRK3 | 0.30761012 |
| 150 | CAMK1G | 0.30485006 |
| 151 | UHMK1 | 0.30448617 |
| 152 | TRPM7 | 0.30180017 |
| 153 | RIPK1 | 0.29562333 |
| 154 | CSNK1D | 0.27999046 |
| 155 | CSNK1G2 | 0.27640396 |
| 156 | PRKACB | 0.27198538 |
| 157 | MAPKAPK2 | 0.27013607 |
| 158 | MAPKAPK5 | 0.26380839 |
| 159 | CSNK1G1 | 0.26332377 |
| 160 | GSK3B | 0.24056835 |
| 161 | PRKD1 | 0.23702818 |
| 162 | PRKCD | 0.22481420 |
| 163 | NTRK2 | 0.22246963 |
| 164 | PRKD2 | 0.22077018 |
| 165 | PLK1 | 0.21509781 |
| 166 | MAPK1 | 0.20305287 |
| 167 | ROCK2 | 0.20254623 |
| 168 | MARK1 | 0.19877447 |
| 169 | WNK4 | 0.19398542 |
| 170 | DYRK1B | 0.19132555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.97566300 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.67279328 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.14810476 |
| 4 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.87382275 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.78615639 |
| 6 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.76228314 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.69300818 |
| 8 | Cell cycle_Homo sapiens_hsa04110 | 2.68294765 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.67504280 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.55949248 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 2.35971438 |
| 12 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.25122552 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.18905733 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.15192272 |
| 15 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.07654341 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.92342536 |
| 17 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.91146926 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.82575225 |
| 19 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.79333858 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.73150268 |
| 21 | Spliceosome_Homo sapiens_hsa03040 | 1.71321478 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.66656927 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.65338819 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.54820468 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.54758098 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.53087869 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.51099606 |
| 28 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.50488699 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.50310853 |
| 30 | Axon guidance_Homo sapiens_hsa04360 | 1.50014056 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.47302642 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.45475168 |
| 33 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.41159088 |
| 34 | Tight junction_Homo sapiens_hsa04530 | 1.37250397 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.36618266 |
| 36 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.36507401 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.34916118 |
| 38 | Proteasome_Homo sapiens_hsa03050 | 1.32359713 |
| 39 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.31814658 |
| 40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.31749057 |
| 41 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.31489579 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31269151 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.27330127 |
| 44 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25633030 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25285315 |
| 46 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.24566285 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23335746 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15549083 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.14190862 |
| 50 | RNA polymerase_Homo sapiens_hsa03020 | 1.13081480 |
| 51 | Pathways in cancer_Homo sapiens_hsa05200 | 1.11801114 |
| 52 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.10932381 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10829656 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.10015692 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09272778 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.09254023 |
| 57 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.08496280 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.07244947 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06171325 |
| 60 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.05397934 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04588450 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.04327642 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 1.02550611 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00693012 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98021011 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.97096538 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96150361 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95184795 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.93866085 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93662997 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.93393693 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92836288 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.92281351 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.92089543 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.90960689 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.90909871 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90451743 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.89890706 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89276376 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87220896 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86834705 |
| 82 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86098927 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85403265 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84258777 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82324063 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79800846 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.79738755 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.75837240 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75237678 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.75073632 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75002959 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73953943 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.72969434 |
| 94 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71026550 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70627252 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.70453683 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70219425 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69035336 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68927047 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68843619 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68267761 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65396281 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63733280 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62920585 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.62887899 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.62784325 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.62737317 |
| 108 | Long-term depression_Homo sapiens_hsa04730 | 0.61647641 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60522764 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60169131 |
| 111 | GABAergic synapse_Homo sapiens_hsa04727 | 0.59934479 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58773270 |
| 113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58548012 |
| 114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58347217 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57571395 |
| 116 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56444711 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56192421 |
| 118 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.55660328 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55339075 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54313296 |
| 121 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53388932 |
| 122 | Purine metabolism_Homo sapiens_hsa00230 | 0.52429464 |
| 123 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52084528 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52072934 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51139222 |
| 126 | Focal adhesion_Homo sapiens_hsa04510 | 0.50988398 |
| 127 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50345393 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50244997 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49910907 |
| 130 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49375786 |
| 131 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48659280 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48510714 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47743657 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.47429783 |
| 135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46501425 |
| 136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46384981 |
| 137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45845423 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45688490 |
| 139 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44869854 |
| 140 | Hepatitis C_Homo sapiens_hsa05160 | 0.43422061 |
| 141 | Melanogenesis_Homo sapiens_hsa04916 | 0.41858172 |
| 142 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41382400 |
| 143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39846034 |
| 144 | Legionellosis_Homo sapiens_hsa05134 | 0.39065286 |
| 145 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38439681 |
| 146 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37160180 |
| 147 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37128952 |
| 148 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36925923 |
| 149 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36643361 |
| 150 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36624897 |
| 151 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35775213 |
| 152 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.35575312 |
| 153 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.35448471 |
| 154 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.33730709 |
| 155 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33326378 |
| 156 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33123228 |
| 157 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32996996 |
| 158 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32944441 |
| 159 | Endocytosis_Homo sapiens_hsa04144 | 0.32747587 |
| 160 | Salivary secretion_Homo sapiens_hsa04970 | 0.32354307 |
| 161 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32163650 |
| 162 | Melanoma_Homo sapiens_hsa05218 | 0.30354366 |

